Using information provision to increase interest in genetic research participation

How to cite

Peters, Shaquille; Meer, Janna Ter; Quer, Giorgio. 2020. "Using information provision to increase interest in genetic research participation." AEA RCT Registry. AEARCTR-0006601. https://doi.org/10.1257/rct.6601-1.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Shaquille Peters* , Janna Ter Meer , Giorgio Quer

* Primary investigator

Registry ID
AEARCTR-0006601
DOI
https://doi.org/10.1257/rct.6601-1.0
First registered
Last updated
Status
In development
Trial dates
2020-11-03 – 2020-12-16
Countries
Private
JEL codes
I14, I18, I11, C91
Registry record
http://www.socialscienceregistry.org/trials/6601

Abstract

With large-scale efforts for COVID-19 vaccine development underway, there is a spotlight on participation in medical research studies in general, and efforts to improve inclusivity and diversity in particular. Research programs often adopt information-based approaches to increase interest in research participation. It is difficult to determine the efficacy of such approaches because of confounds with information comprehension as well as a possible disconnect between information provision and specific concerns that a target population might have. In addition, certain demographic subgroups may have stronger or different barriers to research engagement, which can impact the efficacy of targeted and comprehensive information provision. For example, previous research has found that many marginalized communities are distrustful of research and research organizations, possibly as a result of having endured historical atrocities in the name of research. We evaluate the effectiveness of information provision in a large online experiment where individuals are randomly assigned to different recruitment materials for a genetic research program and give participants the opportunity to sign up to take part. We experimentally test the impact of recruitment materials emphasizing the trustworthiness of genomic research and the organization or perceived benefits of participating for the individual and their community, which previous work suggests are two key barriers to research participation, particularly for ethnic minorities. This is compared against baseline recruitment materials that give only general information about the program. The findings from this study will inform whether different types of information provision are effective for recruitment into a genomic research program, particularly among a socio-demographically diverse population.

Intervention

The trial will focus on how different types of information provision influence participant behavior. This study will comprise of three arms:
● Arm 1: Baseline genomics research recruitment information with no extra information provision.
● Arm 2: Baseline genomics research recruitment information and additional information targeted at improving trust in genomics research. This arm aims to increase the participant's trust in genomics research by explaining how their privacy will be protected, how they can communicate with the study coordinators or support center if they have any questions and how the research study would protect them against risks.
● Arms 3: Baseline genomics research recruitment information and additional information targeted at improving the perceived benefits of genomics research. In this arm, various additional benefits are explained including: how joining the research study could improve their health, how joining could benefit their family and community and what they could learn about their own health.

Experimental design

This study will take place on Predictiv (www.predictiv.co.uk), an online platform for running behavioral experiments built by the Behavioral Insights Team. Predictiv provides access to a large panel, including over 2 million individuals in the US, as well as the functionality to run a range of online experiments, such as choice simulations and comprehension tests.

Participants will be recruited from the general public via a network of panel providers to the Predictiv platform. They will be able to view a brief description of the study before entering the platform, to help them decide if they want to take part. These participants have already consented with their respective panel provider to take part in online research and be contacted about studies for which they are eligible. In addition, they will be explicitly asked if they want to take part in this study after receiving general information about the study, including the task, duration of the experiment and compensation.

We will aim to recruit 4200 participants from the general public via the panel providers connected to the Predictiv platform. We will use sample quotes to recruit a socio-demographically diverse sample as follows:
● Race : 48% white, 52% non-white
● Age : 85% 18-64 years, 15% 65+ years
● Sex : 50% male, 50% female
● Household income : 31% income under $25,000, 69% income over $25,000
● Education : 88% high school or more, 12% less than high school
● Geography : 94% urban/metropolitan, 6% rural (note: We will aim to oversample participants from rural areas so that they make up 10% of the total sample, in order to be able to provide more precise descriptive statistics about them.)

Participants will be pre-screened on the above demographics before being able to access the Predictiv platform. Once we have reached a quota, new participants with that characteristic will not be able to enter the experiment.

Once recruited from the Predictiv platform, the participant is shown a welcome screen which orients them to the experiment tasks and the duration of the study. After giving consent, the participant is presented with a summary screen detailing the various parts of the study, the duration (8-10 minutes). Participants receive a fixed compensation from their panel provider based on the experiment duration (estimated at around $1.50 to $2.50 depending on their specific demographic - this variability is due to the fact that participant compensation is determined dynamically using a marketplace format). In addition, the participant can earn additional variable compensation of a maximum of $1.00 (in the control condition) or $2.00 (in the trust and perceived benefits conditions). Information on variable compensation is provided to participants during the instructions.

To begin the study, the participant answers demographic questions about themselves including age, gender, insurance status, and ethnicity. After answering the demographic questions, participants are asked to review recruitment materials for a hypothetical research program. The recruitment materials differ depending on the treatment condition the participant has been assigned to. After seeing the recruitment materials, the participant is asked whether they would join a similar research program. If answered affirmatively, the participant has an opportunity to provide their email address to receive an invitation to join a similar research program. Those who answered they would not join the research program are asked their reasons for not joining. The participant is then asked to complete a survey with their opinions about the research program which aims to assess their level of trust and their perceived value of participating in genomic research. A comprehension quiz is then conducted to assess their understanding of the research program, earning them an additional $0.25 for each correct response. The final section of the study asks the participant to answer a series of belief questions about what they think the research program offers (corresponding to the program components the participant did not see recruitment materials about). These are questions are not incentivized.

The study will be active in the Predictiv system for an estimated four weeks allowing for individuals to participate in the study.

Design details

Randomization method
Once they consent, participants are randomly assigned a number between 1 and 3, which corresponds to one of the three trial arms.
Randomization unit
The unit of randomization is at the individual participant level. This happens when participants enter the experiment and individuals are not re-randomized.
Clusters
N/A
Observations
Approximately 4200 persons
Arms
Approximately 1400 persons per arm.
Primary outcomes
The primary endpoint is the participants' interest in participating in a pharmacogenomics research program, signaled through the provision of the person’s email address. This is coded as a binary measure, with a value of 1 if the participant leaves their email address and 0 otherwise.
Secondary outcomes
The secondary endpoints include: 1. Trust in the genomics research program 2. Perception of benefits of participating in genomics research 3. Comprehension of PGx testing and results, research safeguards, and research benefits

Cited by

No citation data available for this registration yet.

Keywords